Drug
Coumadin
Coumadin is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph phase_3
1
20%
Ph not_applicable
2
40%
Ph phase_2
1
20%
Ph phase_1
1
20%
Phase Distribution
1
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Other(2)
Detailed Status
Completed3
unknown2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
N/A2 (40.0%)
Trials by Status
unknown240%
completed360%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood
NCT04679948
unknownnot_applicable
Comparison of the Efficacy of Rivroxaban to Coumadin( Warfarin ) in Cerebral Venous Thrombosis
NCT03191305
completedphase_2
Odiparcil For The Prevention Of Venous Thromboembolism
NCT00244725
completedphase_3
Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation
NCT01006876
unknownnot_applicable
Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing
NCT00484640
Clinical Trials (5)
Showing 5 of 5 trials
NCT04679948Phase 1
A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood
NCT03191305Not Applicable
Comparison of the Efficacy of Rivroxaban to Coumadin( Warfarin ) in Cerebral Venous Thrombosis
NCT00244725Phase 2
Odiparcil For The Prevention Of Venous Thromboembolism
NCT01006876Phase 3
Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation
NCT00484640Not Applicable
Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5